XML 41 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Deficit (Tables)
6 Months Ended
Oct. 31, 2018
Equity [Abstract]  
Summary of Information and Activity Relating to Outstanding and Exercisable Warrants

The following table summarizes certain information relating to outstanding and exercisable warrants as of October 31, 2018:

 

Warrants Outstanding     Warrants Exercisable  
Number of
Shares
    Weighted
Average Remaining
Contractual
life (in years) (1)
    Weighted
Average
Exercise
Price (1)
    Number of
Shares
   

Weighted

Average
Exercise
Price (1)

 
  2,160,000       4.6     $ 0.22       2,160,000     $ 0.22  
  333,333       3.9     $ 0.15       333,333     $ 0.15  

  

  (1) Between April 2018 and October 2018, in conjunction with the sale, in the aggregate, of 2,160,000 shares of its common stock pursuant to stock subscription agreements, the Company granted warrants to purchase up to 2,160,000 shares of its common stock at a price determined by the average trading price per share of the Company common stock.

Schedule of Warrant Activity

The following table summarizes the activity relating to the Company’s warrants during the six months ended October 31, 2018:

 

    Number of
Warrants
   

Weighted

Average Exercise
Price (1)

    Weighted Average
Remaining Term (1)
 
Outstanding at April 30, 2018     6,643,333     $ 0.08       4.7  
Granted     850,000       0.22       4.9  
Exercised     (5,000,000 )     0.0001       -  
Expired     -       -       -  
Outstanding at October 31, 2018     2,493,333     $ 0.21       4.5  

 

  (1) In October 2018, an executive officer of the Company exercised warrants (granted in connection with his employment agreement disclosed previously) to purchase 5,000,000 shares of the Company’s Series A Convertible Preferred Stock at the exercise price of $0.0001. Between April 2018 and October 2018, in conjunction with the sale, in the aggregate, of 2,160,000 shares of its common stock pursuant to stock subscription agreements, the Company granted warrants to purchase up to 2,160,000 shares of its common stock at a price determined by the average trading price per share of the Company common stock.